We suggest that future therapeutic strategies targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 represent ...

A new mini review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, "Linking FOXM1 and PD-L1 to CDK4/6 ...

Immune checkpoint inhibitors industry is projected to witness a CAGR of 16.7% during the period 2024-2032. This growth can be ...

如果委员会的投票结果被FDA采纳，FDA进而收窄相关适应证，中国是否会跟进？

9 月已经结束。根据 Insight 数据库，有 9 款为抗肿瘤新药在九月向 CDE 递交了上市申请，包括 4 个新药的首次 NDA 和 5 款新药的新适应症/新剂型 NDA，适应症涉及鼻咽癌、大 B ...

WARMINSTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...

Shattuck Labs (STTK – Research Report) received a Hold rating and price target from H.C. Wainwright analyst Joseph Pantginis today. The ...

Analyst Charles Zhu of LifeSci Capital maintained a Buy rating on Merus (MRUS – Research Report), retaining the price target of $100.00.

长圣(6712)受惠于CDMO服务与全台19家医疗机构合作，自结9 月营收以9,002万元再创新高，连续9个月长红，累计前九月营收达5.89 亿元，年增率高达17.16％，再次刷新同期新高纪录，预期第四季营收将更好。总经理黄文良表 ...

▎药明康德内容团队编辑2024年诺贝尔奖进入倒计时。作为科学界的最高荣誉，诺贝尔奖已经走过了一个多世纪。在这100多年里，科学家们取得了一系列突破性发现和研究进展，为科学的发展和人类社会的进步做出了开拓性贡献。在这其中，有一些发现与人类的健康和生命息 ...

Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...

A high density of tumor-associated macrophages (TAMs) is associated with poorer prognosis and survival in breast cancer patients. Recent studies have shown that lipid accumulation in TAMs can promote ...